Astena Holdings Co (TSE:8095) ROCE % : 4.40% (As of Feb. 2024)

View and export this data going back to 1963. Start your Free Trial

What is Astena Holdings Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Astena Holdings Co's annualized ROCE % for the quarter that ended in Feb. 2024 was 4.40%.

Astena Holdings Co ROCE % Historical Data

The historical data trend for Astena Holdings Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astena Holdings Co ROCE % Chart

Astena Holdings Co Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

ROCE %

Get a 7-Day Free Trial

10.07

9.54

9.19

4.05

4.44

Astena Holdings Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
ROCE %	Get a 7-Day Free Trial															-0.79	1.89	6.45	10.37	4.40

Astena Holdings Co ROCE % Calculation

Astena Holdings Co's annualized ROCE % for the fiscal year that ended in Nov. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Nov. 2023 )		(A: Nov. 2022 )		(A: Nov. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Nov. 2023 )		(A: Nov. 2022 )		(A: Nov. 2023 )
	=	1621.137	/	( ( (63551.819 - 27792.074)	+	(67254.75 - 29981.62) )	/ 2 )
	=	1621.137	/	( (35759.745	+	37273.13)	/ 2 )
	=	1621.137	/	36516.4375
	=	4.44 %

Astena Holdings Co's ROCE % of for the quarter that ended in Feb. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Feb. 2024 )		(Q: Nov. 2023 )		(Q: Feb. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Feb. 2024 )		(Q: Nov. 2023 )		(Q: Feb. 2024 )
	=	1635.2	/	( ( (67254.75 - 29981.62)	+	(65912.426 - 28798.213) )	/ 2 )
	=	1635.2	/	( ( 37273.13	+	37114.213 )	/ 2 )
	=	1635.2	/	37193.6715
	=	4.40 %

(1) Note: The EBIT data used here is four times the quarterly (Feb. 2024) EBIT data.

Astena Holdings Co (TSE:8095) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Astena Holdings Co ROCE % Related Terms

Thank you for viewing the detailed overview of Astena Holdings Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Astena Holdings Co (TSE:8095) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Astena Holdings Co Ltd (TSE:8095) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

8-2 Nihonbashi Honcho 4-Chome, Chuo-ku, Tokyo, JPN, 103-8403

Website

http://www.iwaki-kk.co.jp

Astena Holdings Co Ltd formerly Iwaki & Co Ltd is engaged in sale of pharmaceuticals, quasi-medicines, veterinary drugs, and medical equipment. It is also engaged in the sale of raw materials for medicines and cosmetics, health foods, chemicals and synthetic resins.

Astena Holdings Co (TSE:8095) Headlines

No Headlines